Hepatitis C

Infectious Disease Clinics of North America

Volumn 12, Issue 1, 1998, Pages 13-26

  Alter, M J ^a   Mast, E E ^a   Moyer, L A ^a   Margolis, H S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADOLESCENT; ADULT; APATHY; BONE MARROW SUPPRESSION; CHILD; CHRONIC LIVER DISEASE; CLINICAL FEATURE; DEMOGRAPHY; DEPRESSION; DEVELOPED COUNTRY; ENDEMIC DISEASE; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INFANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID ANALYSIS; PERSISTENT INFECTION; PUBLIC HEALTH; REVIEW; RISK FACTOR; SERODIAGNOSIS; UNITED STATES; VIRUS TRANSMISSION;

EID: 0031894550     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70405-0     Document Type: Article

References (89)

1. R.D. Aach C.E. Stevens F.B. Hollinger Hepatitis C virus infection in post-transfusion hepatitis: An analysis with first- and second-generation assays N Engl J Med 325 1991 1325 1329
2. H.J. Alter P.V. Holland A.G. Morrow Clinical and serological analysis of transfusion-associated hepatitis Lancet 2 1975 838 841
3. H.J. Alter B.W. Jett A.J. Polito Analysis of the role of hepatitis C virus in transfusion-associated hepatitis F.B. Hollinger S.M. Lemon H.S. Margolis Viral Hepatitis and Liver Disease 1991 Williams and Wilkins Baltimore 396 402
4. H.J. Alter R.H. Purcell J.W. Shih Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis N Engl J Med 321 1989 1494 1500
5. M.J. Alter Epidemiology of hepatitis C in the west Semin Liver Dis 15 1995 5 14
6. M.J. Alter Residual risk of transfusion-associated hepatitis. NIH Consensus Development Conference on Infectious Disease Testing for Blood Transfusions 1995 National Institutes of Health Bethesda 23 27
7. M.J. Alter Epidemiology of hepatitis C Hepatology 26 1997 62 65
8. M.J. Alter The epidemiology of acute and chronic hepatitis C Clinics in Liver Disease 1 1997 559 568
9. M.J. Alter P.J. Coleman W.J. Alexander Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis JAMA 262 1989 1201 1205
10. M.J. Alter R.J. Gerety L. Smallwood Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban United States population J Infect Dis 145 1982 886 893
11. M.J. Alter S.C. Hadler F.N. Judson Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection JAMA 264 1990 2231 2235
12. M.J. Alter H.S. Margolis K. Krawczynski The natural history of community-acquired hepatitis C in the United States N Engl J Med 327 1992 1899 1905
13. M.J. Alter E.E. Mast The epidemiology of viral hepatitis in the United States Gastroenterol Clin North Am 23 1994 437 455
14. American Academy of Pediatrics Hepatitis C G. Peter 1997 Red Book: Report of the Committee on Infectious Diseases ed 24 1997 American Academy of Pediatrics Elk Grove Village, IL 260 265
15. J.M. Berrera M. Brugera E. Guadalupe Incidence of non-A, non-B hepatitis after screening blood donors for antibodies for hepatitis C virus and surrogate markers Ann Intern Med 115 1991 596 600
16. K. Bjøro S.S. Frøland Z. Yun Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin N Engl J Med 331 1994 1607 1611
17. J.S. Bresee E.E. Mast P.J. Coleman Hepatitis C virus infection associated with administration of intravenous immune globulin JAMA 276 1996 1563 1567
18. J.P. Bronowicki V. Venard C. Botte Patient to patient transmission of hepatitis C virus during colonoscopy N Engl J Med 337 1997 237 240
19. J. Bukh R.H. Miller R.H. Purcell Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes Semin Liver Dis 15 1995 41 63
20. CDC, HRSA, NIDA, SAMHSA Medical advice for persons who inject illicit drugs HIV Prevention Bulletin May 1997
21. Centers for Disease Control Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C MMWR 40 RR-4 1991 1 17
22. Centers for Disease Control and Prevention Outbreak of hepatitis C associated with intravenous immunoglobulin administration—United States, October 1993–June 1994 MMWR 43 1994 505 509
23. Centers for Disease Control and Prevention Transmission of hepatitis C virus infection associated with home infusion therapy for hemophilia MMWR 46 1997 597 599
24. Centers for Disease Control and Prevention Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus MMWR 46 1977 603 606
25. Q.L. Choo G. Kuo A.J. Weiner Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome Science 244 1989 359 362
26. E.U. Conrad D.R. Gretch K.R. Obermeyer Transmission of the hepatitis C virus by tissue transplantation J Bone Joint Surg 77 1995 214 224
27. C. Conry-Cantilena M. VanRaden J. Gibble Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection N Engl J Med 334 1996 1691 1696
28. J. Crowe C. Doyle J.F. Fielding Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [abstract A1054] Gastroenterology 1995 108
29. G.L. Davis J.Y. Lau H.L. Lim Therapy for chronic hepatitis C Gastroenterol Clin North Am 23 1994 603 613
30. G.L. Davis J.Y. Lau M.S. Urdea Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients Hepatology 19 1994 1337 1341
31. M. DeMedina E.R. Schiff Hepatitis C: Diagnostic assays Semin Liver Dis 15 1995 33 40
32. A.M. Di Bisceglie S.E. Order J.L. Klein The role of chronic viral hepatitis in hepatocellular carcinoma in the United States Am J Gastroenterol 86 1991 335 338
33. A.M. Di Bisceglie Z.D. Goodman K.G. Ishak Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis Hepatology 14 1991 969 974
34. J.G. Donahue A. Munoz P.M. Ness The declining risk of post-transfusion hepatitis C virus infection N Engl J Med 327 1992 369 373
35. B.M. Eggen S.A. Nordbo Transmission of HCV by organ transplantation N Engl J Med 326 1992 411
36. J.I. Esteban J. Gomez M. Martell Transmission of hepatitis C virus by a cardiac surgeon N Engl J Med 334 1995 555 560
37. J.I. Esteban J.C. Lopez-Talavera J. Genesca High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus Ann Intern Med 115 1991 443 449
38. P. Farci H.J. Alter S. Govindarajan Lack of protective immunity against reinfection with hepatitis C virus Science 258 1992 135 140
39. P. Farci H.J. Alter D.C. Wong Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization Proc Natl Acad Sci USA 91 1994 7792 7796
40. L.O. Gostin Z. Lazzarini T.S. Jones Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: A national survey on the regulation of syringes and needles JAMA 277 1997 53 62
41. R.S. Garfein D. Vlahov N. Galai Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses Am J Public Health 86 1996 655 661
42. D.R. Gretch C. dela Rosa R.L. Carithers Assessment of hepatitis C viremia using molecular amplification technologies: Correlations and clinical implications Ann Intern Med 123 1995 321 329
43. R. Heimer K. Khoshnood B. Jariwalafreeman Hepatitis in used syringes: The limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens J Infect Dis 173 1996 997 1000
44. J.H. Hoofnagle A.M. Di Bisceglie The treatment of chronic viral hepatitis N Engl J Med 5 1997 347 356
45. M. Houghton A. Weiner J. Han Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease Hepatology 14 1991 381 388
46. E. Kaklamani D. Trichopoulos A. Tzonou Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma JAMA 265 1991 1974 1976
47. K. Kiyosawa T. Sodeyama E. Tanaka Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus Hepatology 12 1990 671 675
48. S. Kleinman H. Alter M. Busch Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay Transfusion 32 1992 805 813
49. S.K. Koester L. Hoffer “Indirect sharing”: Additional HIV risks associated with drug injection AIDS and Public Policy J 9 1994 100 105
50. R.S. Koff J.L. Dienstag Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease Semin Liver Dis 15 1995 101 109
51. R.L. Koretz H. Abbey E. Coleman Non-A, non-B post-transfusion hepatitis: Looking back in the second decade Ann Intern Med 119 1993 110 115
52. R.L. Koretz M. Brezina A.J. Polito Non-A, non-B posttransfusion hepatitis: Comparing C and non-C hepatitis Hepatology 17 1993 361 365
53. G. Kuo Q.L. Choo H.J. Alter An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 244 1989 362 364
54. J.Y. Lau M. Mizokami J.A. Kolberg Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States J Infect Dis 171 1995 281 289
55. Lelie M, Damen HTM, Cuypers HL, et al: International collaborative study on the second Eurohep HCV-RNA reference panel [abstract]. Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease, Rome, 1996, p 25
56. T.J. Liang L. Jeffers R.K. Reddy Fulminant or subfulminant non-A, non-B hepatitis: Hepatitis C and E viruses Gastroenterology 103 1992 556 562
57. H.H. Lin J.H. Kao H.Y. Hsu Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus J Infect Dis 169 1994 638 641
58. B.M. Makris C.J.A. Garson P.W. Ring Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients Blood 81 1993 1898 1902
59. C.J. Mansell S.A. Locarnini Epidemiology of hepatitis C in the east Semin Liver Dis 15 1995 15 32
60. F. Marranconi V. Mecenero G.P. Pellizzer HCV infection after accidental needlestick injury in health-care workers Infection 20 1992 111
61. E.E. Mast M.J. Alter Hepatitis C Seminars in Pediatric Infectious Disease 8 1997 17 22
62. McQuillan G, Alter M, Moyer L, et al: A population based serologic study of hepatitis C virus infection in the United States [abstract]. Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease, Rome, 1996, p 8
63. L. Mimms D. Vallari L. Ducharme Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions Lancet 336 1990 1590 1591
64. T. Mitsui K. Iwano K. Masuko Hepatitis C virus infection in medical personnel after needlestick accident Hepatology 16 1992 1109 1114
65. L.A. Moyer M.J. Alter Hepatitis C virus in the hemodialysis setting: A review with recommendations for control Seminars in Dialysis 7 1994 124 127
66. National Institutes of Health: National Institutes of Health Consensus Development Conference Statement Management of Hepatitis C, Bethesda, MD, March 24–26, 1997
67. J.B. Nousbaum S. Pol B. Nalpas Hepatitis C virus type 1b (II) infection in France and Italy Ann Intern Med 122 1995 161 168
68. H. Ohto S. Terazawa N. Sasaki Transmission of hepatitis C virus from mothers to infants N Engl J Med 330 1994 744 750
69. B.J.G. Pereira E.L. Milford R.L. Kirkman Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs N Engl J Med 327 1992 910 915
70. B.J. Pereira E.L. Milford R.L. Kirkman Low risk of liver disease after tissue transplantation from donors with HCV Lancet 341 1993 903 904
71. T. Poynard P. Bedossa M. Chevallier A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis: Multicenter Study Group N Engl J Med 332 1995 1457 1462
72. T. Poynard P. Bedossa P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 1997 825 832
73. T. Poynard V. Leroy M. Cohard Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration Hepatology 24 1996 778 789
74. W.K. Roth J.-H. Lee B. Rüster Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays J Clin Microbiol 34 1996 261 264
75. M. Sartori G. La Terra M. Aglietta Transmission of hepatitis C via blood splash into conjunctiva Scand J Infect Dis 25 1993 270 271
76. G.B. Schreiber M.P. Busch S.H. Kleinman The risk of transfusion-transmitted viral infections N Engl J Med 334 1996 1685 1690
77. R. Schvarcz Z.B. Yun A. Sonnerborg Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone J Med Virol 46 1995 43 47
78. L.B. Seeff Hepatitis C from a needlestick injury Ann Intern Med 115 1991 411
79. L.B. Seeff Z. Buskell-Bales E.C. Wright Long-term mortality after transfusion-associated non-A, non-B hepatitis N Engl J Med 327 1992 1906 1911
80. L.B. Seeff E.C. Wright H.J. Zimmerman VA cooperative study of posttransfusion hepatitis, 1969–1974: Incidence and characteristics of hepatitis and responsible risk factors Am J Med Sci 270 1975 355 362
81. L. Serfaty O. Chazouilleres J.M. Pawlotsky Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity Gastroenterology 110 1996 291 295
82. A.O. Shakil C. Conry-Cantilena H.J. Alter Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic, and histologic features Ann Intern Med 123 1995 330 337
83. Y.K. Shimizu M. Hijikata A. Iwamoto Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses J Virol 68 1994 1494 1500
84. D.L. Thomas J.M. Zenilman H.J. Alter Sexual transmission of hepatitis C virus among patients attending Baltimore sexually transmitted diseases clinics: An analysis of 309 sex partnerships J Infect Dis 171 1995 768 775
85. F. Tremolada C. Casarin A. Tagger Antibody to hepatitis C virus in post-transfusion hepatitis Ann Intern Med 114 1991 277 281
86. C.L. Troisi F.B. Hollinger W.K. Hoots A multicenter study of viral hepatitis in a United States hemophilic population Blood 81 1993 412 418
87. J.A.R. Van den Hoek H.J.A. Van Haastrecht J. Goudsmit Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam J Infect Dis 160 1990 823 826
88. T.L. Wright Etiology of fulminant hepatic failure: Is another virus involved Gastroenterology 104 1993 640 653
89. M.C. Yu M.J. Tong P. Coursaget Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States J Natl Cancer Inst 82 1990 1038 1041